Homepage

OVERVIEW

Over 5.8 million Americans live with dementia and this number is only expected to increase. Providing essential care to these Americans are 16 million caregivers (typically family members) who sacrifice their time and energy and even their health to provide over 18.5 billion hours of unpaid care each year. Caregivers are critical to the nation’s dementia care system, as they have the potential to slow the decline of their loved ones with dementia. However, this does not come without a cost. Caregivers are more likely to have poorer quality of life and more markers of poor health than non-caregivers. For these reasons, the Virginia Alzheimer’s Disease Center is committed to improving outcomes and disorder trajectories for persons with dementia and their caregivers.

Research Data

1500
+
Patients seen in the Memory Clinic Annually
$79
M
In Aging Related Research Funds
1000
+
VADC Dedicated, Secure, Private Computer Cores
THE RESEARCH TEAM

Learn about the research personnel at the University of Virginia and what we do.

UVA Research News

Image
Ferris

The new findings offer important insights into how and why the plaques form and may explain why genes associated with cholesterol have been linked to increased risk for Alzheimer’s. 

Image
mrna fights AD

UVA Engineering professor Yanjun Qi builds artificial intelligence tools that have the power to turn biomedical data into better medicine.

Image
Immune Cells

The finding could benefit battles against dementia, stroke and other conditions. 

Stay Connected to Research

VADC Research Registry

Are you interested in learning about research opportunities that would be appropriate for you?  Are you a person with memory problems, a caregiver of someone with memory problems, or an interested healthy adult?

 

Upcoming Events

Image
vadcoct21

Virtual (Zoom)

Dr. Harald Sontheimer will be presenting "Astrocyte-Vascular Interactions in normal Aging and Alzheimer Disease."

Image
neuro7-2021rounds

Pinn Hall 1005 / Zoom

UVA Neurology Grand Rounds in association with the Virginia Alzheimer’s Disease Center (VADC) present <

Image
julyspeaker

Virtual (Zoom)

The past decade has seen a revolution in genomic technologies that enable a flood of genome-wide profiling of chromatin marks.